Study on Anticancer Activity of 4, 4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis(azaneylylidene) bis(methaneylylidene) diphenolon Breast Cancer Cells

New medicinal compounds are being evaluated due to the increasing prevalence of cancer in human societies and the necessity to produce new medications for treatment. The new Schiff base compound 4,4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis (azaneylylidene) bis (methaneylylidene) diph...

Full description

Bibliographic Details
Main Authors: B. Saeed, S. Al-Jadaan, B. A Abbas
Format: Article
Language:English
Published: Razi Vaccine and Serum Research Institute 2021-10-01
Series:Archives of Razi Institute
Subjects:
Online Access:https://archrazi.areeo.ac.ir/article_124907_c41de80734ae1cf5b723cc9f98272f27.pdf
_version_ 1819125753808158720
author B. Saeed
S. Al-Jadaan
B. A Abbas
author_facet B. Saeed
S. Al-Jadaan
B. A Abbas
author_sort B. Saeed
collection DOAJ
description New medicinal compounds are being evaluated due to the increasing prevalence of cancer in human societies and the necessity to produce new medications for treatment. The new Schiff base compound 4,4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis (azaneylylidene) bis (methaneylylidene) diphenol, which was previously produced from the reaction of 5,5' [(1,4-Phenelene) bis (1,3,4-thiadiazol-2-amine)] and the para-hydroxy ben aldehyde was synthesized and different concentrations (250 and 300 mg/mL) of this new compound were exposed to breast cancer (MCF-7) cells to examine its cytotoxicity effect. Cell line viability, acridine orange/propidium iodide staining, and DNA fragmentation were assessed in evaluating the antitumor effect of the new composition. Obtained data from cell viability assays demonstrated cytotoxic activity against MCF-7 breast cancer cell lines. No fragmentation was observed in DNA fragmentation of the novel compound base with MCF-7 and Vero cell line. The new Schiff base compound indicated well-defined anti-cancer activity when treated with breast cancer cells (MCF-7). The compound blocked the proliferation of cancer cells without apoptosis. As a consequence of the findings, it was recommended to use this compound in treating breast cancer.
first_indexed 2024-12-22T07:45:09Z
format Article
id doaj.art-69339ffdd7cd47b8a143977a97d81bf0
institution Directory Open Access Journal
issn 0365-3439
2008-9872
language English
last_indexed 2024-12-22T07:45:09Z
publishDate 2021-10-01
publisher Razi Vaccine and Serum Research Institute
record_format Article
series Archives of Razi Institute
spelling doaj.art-69339ffdd7cd47b8a143977a97d81bf02022-12-21T18:33:40ZengRazi Vaccine and Serum Research InstituteArchives of Razi Institute0365-34392008-98722021-10-0176482182710.22092/ari.2021.355941.1742124907Study on Anticancer Activity of 4, 4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis(azaneylylidene) bis(methaneylylidene) diphenolon Breast Cancer CellsB. Saeed0S. Al-Jadaan1B. A Abbas2University of Basrah, Al-Zahraa College of Medicine, Microbiology Department, Basrah, IraqUniversity of Basrah, College of Pharmacy, Pharmaceutical Chemistry Department, Basrah, IraqDepartment of Microbiology, College of Veterinary Medicine, University of Basrah, Basrah, IraqNew medicinal compounds are being evaluated due to the increasing prevalence of cancer in human societies and the necessity to produce new medications for treatment. The new Schiff base compound 4,4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis (azaneylylidene) bis (methaneylylidene) diphenol, which was previously produced from the reaction of 5,5' [(1,4-Phenelene) bis (1,3,4-thiadiazol-2-amine)] and the para-hydroxy ben aldehyde was synthesized and different concentrations (250 and 300 mg/mL) of this new compound were exposed to breast cancer (MCF-7) cells to examine its cytotoxicity effect. Cell line viability, acridine orange/propidium iodide staining, and DNA fragmentation were assessed in evaluating the antitumor effect of the new composition. Obtained data from cell viability assays demonstrated cytotoxic activity against MCF-7 breast cancer cell lines. No fragmentation was observed in DNA fragmentation of the novel compound base with MCF-7 and Vero cell line. The new Schiff base compound indicated well-defined anti-cancer activity when treated with breast cancer cells (MCF-7). The compound blocked the proliferation of cancer cells without apoptosis. As a consequence of the findings, it was recommended to use this compound in treating breast cancer.https://archrazi.areeo.ac.ir/article_124907_c41de80734ae1cf5b723cc9f98272f27.pdfbreast cancerdna laddering assaythiadiazole compound
spellingShingle B. Saeed
S. Al-Jadaan
B. A Abbas
Study on Anticancer Activity of 4, 4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis(azaneylylidene) bis(methaneylylidene) diphenolon Breast Cancer Cells
Archives of Razi Institute
breast cancer
dna laddering assay
thiadiazole compound
title Study on Anticancer Activity of 4, 4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis(azaneylylidene) bis(methaneylylidene) diphenolon Breast Cancer Cells
title_full Study on Anticancer Activity of 4, 4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis(azaneylylidene) bis(methaneylylidene) diphenolon Breast Cancer Cells
title_fullStr Study on Anticancer Activity of 4, 4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis(azaneylylidene) bis(methaneylylidene) diphenolon Breast Cancer Cells
title_full_unstemmed Study on Anticancer Activity of 4, 4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis(azaneylylidene) bis(methaneylylidene) diphenolon Breast Cancer Cells
title_short Study on Anticancer Activity of 4, 4'-[1,4-phenylenebis(1,3,4-thiadiazole-5,2-diyl)] bis(azaneylylidene) bis(methaneylylidene) diphenolon Breast Cancer Cells
title_sort study on anticancer activity of 4 4 1 4 phenylenebis 1 3 4 thiadiazole 5 2 diyl bis azaneylylidene bis methaneylylidene diphenolon breast cancer cells
topic breast cancer
dna laddering assay
thiadiazole compound
url https://archrazi.areeo.ac.ir/article_124907_c41de80734ae1cf5b723cc9f98272f27.pdf
work_keys_str_mv AT bsaeed studyonanticanceractivityof4414phenylenebis134thiadiazole52diylbisazaneylylidenebismethaneylylidenediphenolonbreastcancercells
AT saljadaan studyonanticanceractivityof4414phenylenebis134thiadiazole52diylbisazaneylylidenebismethaneylylidenediphenolonbreastcancercells
AT baabbas studyonanticanceractivityof4414phenylenebis134thiadiazole52diylbisazaneylylidenebismethaneylylidenediphenolonbreastcancercells